Koumaki D, Orton D. Blue urticaria following Patent Blue V and morphine injections. Clin Case Rep. 2020;8:923--924. 10.1002/ccr3.2748

1. CLINICAL IMAGE {#ccr32748-sec-0001}
=================

A 54‐year‐old female with a history of breast cancer received a subareolar injection of Patent Blue V dye into her left breast before wide local excision and sentinel node biopsy. On transfer to recovery, she received a further 5 mg of intravenous morphine for analgesia into a cannula sited in the dorsum of her right hand. A blood pressure cuff had been inflated around her right arm during this injection, and there was a failure to deflate the cuff before the morphine was administered. She subsequently developed blue wheals on her right arm (Figure [1](#ccr32748-fig-0001){ref-type="fig"}) secondary to localized histamine release from the morphine. Once the reaction was observed, intramuscular adrenaline 0.5 mg, intravenous (iv) hydrocortisone 100 mg, and intravenous (iv) chlorphenamine maleate 10mg were immediately administered.

![Localized blue wheals following morphine injection on the right arm](CCR3-8-923-g001){#ccr32748-fig-0001}

1.1. What is your diagnosis? {#ccr32748-sec-0002}
----------------------------

Blue urticaria.

2. DISCUSSION {#ccr32748-sec-0003}
=============

Opiates are known to cause histamine release that may result in cutaneous adverse drug reactions such as urticaria, erythema, pruritus, and sometimes pseudoallergic anaphylactoid reactions.[1](#ccr32748-bib-0001){ref-type="ref"}, [2](#ccr32748-bib-0002){ref-type="ref"} In our case, the patient experienced a non‐IgE‐mediated urticarial reaction to the morphine injection which was tinted blue due to prior subareolar injection of Patent Blue V dye into her left breast.
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